Predisposing Factors, Control Strategies, and Antiviral Therapy of Mpox Virus as a Potential Zoonotic Agent

Elham Zarenezhad1, Mahrokh Marzi1, Fattma A Ali2

  • 1Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.

Insights

Mpox virus, a zoonotic agent, has seen a resurgence due to behavioral factors. Combination therapy and drug repositioning show promise for antiviral treatment, requiring global collaboration for control.

Area of Science:

  • Virology
  • Immunology
  • Epidemiology

Background:

  • Monkeypox (Mpox) virus, a virulent zoonotic agent from the Poxviridae family, has proven difficult to eradicate.
  • Lack of approved vaccines and antiviral agents, coupled with environmental, social, and behavioral factors, contribute to its persistence.

Purpose of the Study:

  • To assess predisposing factors for Mpox infection.
  • To review current control strategies for Mpox.
  • To evaluate antiviral therapy options for Mpox virus.

Main Methods:

  • Systematic review of published data on Mpox.
  • Analysis of epidemiological data from March 2022 to September 2023.
  • Examination of viral immunoregulatory proteins and host genetic factors.

Main Results:

  • The recent Mpox outbreak involved over 91,000 cases and 157 deaths, linked to human behavioral factors.
  • Viral proteins (e.g., vaccinia complement control protein) suppress host immune responses.
  • Host genetic variations (IL1RN, IL12RB2) and interferon-α deficiency increase Mpox severity.

Conclusions:

  • Combination therapy and drug repositioning are promising for effective Mpox antiviral treatment.
  • Enhanced global collaboration is crucial for improved outbreak preparedness and infection control.

Related Concept Videos

Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.9K
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.9K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.3K
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
14.6K